These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24663086)

  • 1. Albumin suppresses human hepatocellular carcinoma proliferation and the cell cycle.
    Nojiri S; Joh T
    Int J Mol Sci; 2014 Mar; 15(3):5163-74. PubMed ID: 24663086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells.
    Shimizu M; Suzui M; Deguchi A; Lim JT; Xiao D; Hayes JH; Papadopoulos KP; Weinstein IB
    Clin Cancer Res; 2004 Oct; 10(19):6710-21. PubMed ID: 15475462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells.
    Wu Q; Qin SK; Teng FM; Chen CJ; Wang R
    J Hematol Oncol; 2010 Oct; 3():43. PubMed ID: 21034513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E167K polymorphism of TM6SF2 gene affects cell cycle of hepatocellular carcinoma cell HEPA 1-6.
    Du S; Lu L; Miao Y; Jin W; Li C; Xin Y; Xuan S
    Lipids Health Dis; 2017 Apr; 16(1):76. PubMed ID: 28407767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of apoptotic effects induced selectively by ursodeoxycholic acid on human hepatoma cell lines.
    Liu H; Qin CY; Han GQ; Xu HW; Meng M; Yang Z
    World J Gastroenterol; 2007 Mar; 13(11):1652-8. PubMed ID: 17461466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.
    Wang J; Zheng T; Chen X; Song X; Meng X; Bhatta N; Pan S; Jiang H; Liu L
    J Gastroenterol Hepatol; 2011 Feb; 26(2):371-7. PubMed ID: 21261729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
    Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
    BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine inhibits hepatocyte proliferation via endoplasmic reticulum stress.
    Yu X; Lv J; Zhu Y; Duan L; Ma L
    PLoS One; 2013; 8(1):e54265. PubMed ID: 23349842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of alpha-fetoprotein expression inhibits HepG2 cell growth and induces apoptosis.
    Yang X; Chen L; Liang Y; Si R; Jiang Z; Ma B; Gao P
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S634-S643. PubMed ID: 30249880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801.
    Yamaguchi F; Hirata Y; Akram H; Kamitori K; Dong Y; Sui L; Tokuda M
    BMC Cancer; 2013 Oct; 13():468. PubMed ID: 24112473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D.
    Das SK; Hashimoto T; Kanazawa K
    Biochim Biophys Acta; 2008 Apr; 1780(4):743-9. PubMed ID: 18230364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression and effects the CABYR-c transcript of CABYR gene in hepatocellular carcinoma.
    Li H; Fang L; Xiao X; Shen L
    Bull Cancer; 2012 Mar; 99(3):E26-33. PubMed ID: 22285430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel anticancer agent, SKLB70359, inhibits human hepatic carcinoma cells proliferation via G0/G1 cell cycle arrest and apoptosis induction.
    Dai XY; Zeng XX; Peng F; Han YY; Lin HJ; Xu YZ; Zhou T; Xie G; Deng Y; Mao YQ; Yu LT; Yang L; Zhao YL
    Cell Physiol Biochem; 2012; 29(1-2):281-90. PubMed ID: 22415097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor.
    Zhang ZL; Liu GC; Peng L; Zhang C; Jia YM; Yang WH; Mao L
    Gene Ther; 2018 Jul; 25(4):284-296. PubMed ID: 29802374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
    Cai X; Hu X; Cai B; Wang Q; Li Y; Tan X; Hu H; Chen X; Huang J; Cheng J; Jing X
    Oncol Rep; 2013 Nov; 30(5):2449-57. PubMed ID: 24008375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TERT upregulation promotes cell proliferation via degradation of p21 and increases carcinogenic potential.
    Mishima M; Takai A; Takeda H; Iguchi E; Nakano S; Fujii Y; Ueno M; Ito T; Teramura M; Eso Y; Shimizu T; Maruno T; Hidema S; Nishimori K; Marusawa H; Hatano E; Seno H
    J Pathol; 2024 Nov; 264(3):318-331. PubMed ID: 39329419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
    Li J; Chen X; Dong X; Xu Z; Jiang H; Sun X
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth arrest induced by C75, A fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma.
    Gao Y; Lin LP; Zhu CH; Chen Y; Hou YT; Ding J
    Cancer Biol Ther; 2006 Aug; 5(8):978-85. PubMed ID: 16855382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.